These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3691159)

  • 21. Effect of supplementation of ergosterol on miconazole action in vivo and in vitro in Candida albicans.
    Mago N; Khuller GK
    Indian J Exp Biol; 1991 Sep; 29(9):841-4. PubMed ID: 1794867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Susceptibility to antifungal agents of Candida species isolated from paediatric and adult patients with haematological diseases.
    Nawrot U; Nowicka J; Juszczak K; Gusin B
    Mycoses; 2005 Nov; 48(6):385-90. PubMed ID: 16262874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Respiratory deficiency enhances the sensitivity of the pathogenic fungus Candida to photodynamic treatment.
    Chabrier-Roselló Y; Foster TH; Mitra S; Haidaris CG
    Photochem Photobiol; 2008; 84(5):1141-8. PubMed ID: 18248505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ketoconazole-resistant mutants of Microsporum gypseum. II. Characteristics of mutants.
    Lenhart K; Merkunová A; Walterová D; Latinák J; Kozený M
    Acta Univ Palacki Olomuc Fac Med; 1989; 122():71-82. PubMed ID: 2530848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of ATP in Candida albicans by imidazole and derivative antifungal agents.
    Odds FC; Cheesman SL; Abbott AB
    Sabouraudia; 1985 Dec; 23(6):415-24. PubMed ID: 3913012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
    Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA
    J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Identification and susceptibility of clinically isolated yeast-like fungi].
    Fukuchi K; Tanaka Y; Oguro T; Wakuta R; Sugita M; Takagi Y; Gomi K
    Rinsho Byori; 1990 Aug; 38(8):931-6. PubMed ID: 2232256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased permeability of glycerol in an ergosterol-less mutant of Candida albicans.
    Pesti M; Novák R
    Acta Microbiol Hung; 1984; 31(2):81-4. PubMed ID: 6380195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Further studies on factors controlling phenotypic susceptibility of Candida albicans to miconazole kill.
    Beggs WH
    Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):159-62. PubMed ID: 2183320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-Fluorocytosine antagonizes the action of sterol biosynthesis inhibitors in Candida glabrata.
    Siau H; Kerridge D
    J Antimicrob Chemother; 1999 Jun; 43(6):767-75. PubMed ID: 10404315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative study of two systems for the determination of the sensitivity of yeasts to antifungal agents].
    de Montclos M; de Montclos H; Flandrois JP
    Pathol Biol (Paris); 1992 May; 40(5):495-9. PubMed ID: 1495833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disappearance of nystatin resistance in Candida mediated by ergosterol.
    Mas J; Piña E
    J Gen Microbiol; 1980 Mar; 117(1):249-52. PubMed ID: 6993624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metal complexes of 1,10-phenanthroline-5,6-dione alter the susceptibility of the yeast Candida albicans to amphotericin B and miconazole.
    Eshwika A; Coyle B; Devereux M; McCann M; Kavanagh K
    Biometals; 2004 Aug; 17(4):415-22. PubMed ID: 15259362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Laboratory and clinical study of intravenous miconazole].
    Sawae Y; Okada K; Kumagai Y
    Jpn J Antibiot; 1987 Feb; 40(2):271-83. PubMed ID: 3599380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance of Candida albicans to direct lethal miconazole action induced by low-level miconazole.
    Beggs WH
    Mycoses; 1991; 34(5-6):227-30. PubMed ID: 1795717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contact imidazole activity against resistant bacteria and fungi.
    Simonetti G; Baffa S; Simonetti N
    Int J Antimicrob Agents; 2001 May; 17(5):389-93. PubMed ID: 11337226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance to fluorouracil in Candida utilis: effects on the uptake of pyrimidines and amino acids.
    Wild DG; Wilson GI
    J Gen Microbiol; 1981 Nov; 127(1):45-53. PubMed ID: 6802935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of altered ergosterol content on the transport of various amino acids in Candida albicans.
    Singh M; Jayakumar A; Prasad R
    Biochim Biophys Acta; 1979 Jul; 555(1):42-55. PubMed ID: 383149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mode of action of miconazole on yeasts: inhibition of the mitochondrial ATPase.
    Portillo F; Gancedo C
    Eur J Biochem; 1984 Sep; 143(2):273-6. PubMed ID: 6236081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of phenotypic resistance to direct lethal miconazole action by Candida albicans entering stationary phase.
    Beggs WH
    Mycopathologia; 1989 Dec; 108(3):201-6. PubMed ID: 2693969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.